Kelley Discusses Efficacy and Safety Considerations With the STRIDE Regimen in HCC
0
0
2 Просмотры·
08/31/23
Dr Kelley discusses standard first-line treatment options for patients with advanced HCC, key findings from the phase 3 HIMALAYA trial, and the safety profile of the STRIDE regimen in this population.
Показать больше
0 Комментарии
sort Сортировать по